药物审查过程的进步和所需的制造商和合同研究或组织的响应
Takayuki Anzai1, Glenn J Myatt2, Frances Hall2
1Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa, Tokyo 142-0064, Japan.
Journal of toxicologic pathology
|April 8, 2024
概括
美国食品和药物管理局现代化法案2.0鼓励在药物开发中减少动物试验. 本研究探讨生物信息学和新技术作为确保药物安全和应用完整性的替代方案.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 生物技术是生物技术.
- 监管科学 监管科学
背景情况:
- 美国食品和药物管理局现代化法案2.0旨在减少药物开发中的强制性动物试验.
- 社会压力和道德考虑正在增加对动物试验替代品的需求.
- 制药公司优先考虑患者安全,影响采用新的测试方法.
研究的目的:
- 探索生物信息学和新技术作为药物开发中的动物试验的替代品.
- 评估减少动物试验将如何影响未来的新药应用.
- 为制药公司和合同研究组织提供关于采用3Rs (替代,减少,改进) 的指导.
主要方法:
- 文献审查和对药物开发和监管变化趋势的分析.
- 探索生物信息学工具和用于临床前药物评估的新技术.
- 讨论在制药研究中实施替代方法的策略.
主要成果:
- 美国食品和药物管理局 (FDA) 现代化法案2.0意味着远离强制性动物测试的转变,尽管它的直接影响有限.
- 生物信息学和先进技术提供了可行的替代方案,以弥补减少的动物数据.
- 预计向替代方法的过渡将重塑未来的药物应用.
结论:
- 制药行业必须适应不断变化的法规和社会对动物试验的期望.
- 采用生物信息学和新技术对于在减少动物使用的情况下保持药物安全性和有效性至关重要.
- 对于非临床合同研究组织和制药公司来说,对3Rs的战略实施至关重要.
更多相关视频
相关概念视频
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:26Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
01:19Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
01:26Drug Administration and Therapy Phases: Overview
454
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
454